Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging in the differential diagnosis of parotid tumors
暂无分享,去创建一个
Xiaofeng Tao | Ying Yuan | Shiyu Xiang | Jiliang Ren | Zhipeng Xia | Xiaofeng Tao | Ying Yuan | Jiliang Ren | Shi Xiang | Zhipeng Xia
[1] Faiza Admiraal-Behloul,et al. Reproducibility of brain ADC histograms , 2004, European Radiology.
[2] Jingliang Cheng,et al. Apparent diffusion coefficient (ADC) histogram analysis: Differentiation of benign from malignant parotid gland tumors using readout-segmented diffusion-weighted imaging. , 2019, Dento maxillo facial radiology.
[3] H. Matsuzaki,et al. Assessment of pleomorphic adenomas using MRI and dynamic contrast enhanced MRI. , 2003, Oral oncology.
[4] N. Just,et al. Improving tumour heterogeneity MRI assessment with histograms , 2014, British Journal of Cancer.
[5] T. Kurabayashi,et al. Differentiating benign and malignant salivary gland tumours: diagnostic criteria and the accuracy of dynamic contrast-enhanced MRI with high temporal resolution. , 2015, The British journal of radiology.
[6] Publisher's Note , 2018, Anaesthesia.
[7] Xiaofeng Tao,et al. The histogram analysis of apparent diffusion coefficient in differential diagnosis of parotid tumor. , 2020, Dento maxillo facial radiology.
[8] C. West,et al. Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review. , 2014, Oral oncology.
[9] Jeong Hyun Lee,et al. Detection of Local Tumor Recurrence After Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Histogram Analysis of Dynamic Contrast-Enhanced T1-Weighted Perfusion MRI. , 2017, AJR. American journal of roentgenology.
[10] A. Surov,et al. Associations between histogram analysis parameters derived from dynamic-contrast enhanced MRI and PD L1-expression in head and neck squamous cell carcinomas. A preliminary study. , 2020, Magnetic resonance imaging.
[11] E. Gökçe. Multiparametric Magnetic Resonance Imaging for the Diagnosis and Differential Diagnosis of Parotid Gland Tumors , 2020, Journal of magnetic resonance imaging : JMRI.
[12] R. Spiro. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. , 1986, Head & neck surgery.
[13] Weiqing Gao,et al. The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours. , 2017, Dento maxillo facial radiology.
[14] H. Huisman,et al. Correlation between dynamic contrast-enhanced MRI and quantitative histopathologic microvascular parameters in organ-confined prostate cancer , 2014, European Radiology.
[15] H. Shindo,et al. [Salivary gland masses: dynamic MR imaging and pathologic correlation]. , 1997, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.
[16] Peng Cao,et al. Benign and malignant orbital lymphoproliferative disorders: Differentiating using multiparametric MRI at 3.0T , 2017, Journal of magnetic resonance imaging : JMRI.
[17] A. Parwani,et al. Diagnostic accuracy and pitfalls in fine‐needle aspiration interpretation of Warthin tumor , 2003, Cancer.
[18] T. Yoshiura,et al. Value of diffusion tensor imaging in differentiating malignant from benign parotid gland tumors. , 2017, European journal of radiology.
[19] P. Westesson,et al. Tumors of the parotid gland: MR imaging characteristics of various histologic types. , 1994, AJR. American journal of roentgenology.
[20] M. Fležar,et al. Warthin's tumour: unusual vs. common morphological findings in fine needle aspiration biopsies , 2002, Cytopathology : official journal of the British Society for Clinical Cytology.
[21] K. Mackenzie,et al. Fine‐needle aspiration cytology of salivary gland: A review of 341 cases , 2000, Diagnostic cytopathology.
[22] Hidetake Yabuuchi,et al. Index terms: , 2002 .
[23] H. Matsuzaki,et al. Diagnostic value of dynamic contrast-enhanced MRI in the salivary gland tumors. , 2007, Oral oncology.
[24] T. Murakami,et al. Contrast‐enhanced MR imaging of intrahepatic cholangiocarcinoma: Pathologic correlation study , 1995, Journal of magnetic resonance imaging : JMRI.
[25] Steven R. Breault,et al. Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis. , 2013, Radiology.
[26] Jong-Hee Chang,et al. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient , 2017, European Radiology.
[27] W. Qian,et al. Histogram analysis of apparent diffusion coefficient maps for differentiating malignant from benign parotid gland tumors , 2018, European Archives of Oto-Rhino-Laryngology.
[28] Hu Liu,et al. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders , 2019, Acta radiologica.
[29] H. Matsuzaki,et al. Assessment of dynamic MRI of Warthin's tumors arising as multiple lesions in the parotid glands. , 2002, Oral oncology.
[30] Tao Zhang,et al. Magnetic resonance image biomarkers improve differentiation of benign and malignant parotid tumors through diagnostic model analysis , 2021, Oral Radiology.
[31] Philip Cole,et al. Incidence Rates of Salivary Gland Tumors: Results from a Population-Based Study , 1999, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.